Consequently, the research pinpointed four key genes, MBP, CYP4B1, ERMN, and SLC26A7, which hold clinical relevance and exhibit potential significance in the pathophysiology of COVID-19 induced depression (Zhuang et al., 2024). This evidence concerns the gene CYP4B1 and major depressive disorder.